J.P. Morgan analyst Cory Kasimov reiterated a Buy rating on Global Blood Therapeutics (GBT – Research Report) on November 7
Tag: GBT
Wedbush Reiterates a Buy Rating on Global Blood Therapeutics (GBT)
Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set a
H.C. Wainwright Sticks to Their Buy Rating for Global Blood Therapeutics (GBT)
H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set
Analysts Offer Insights on Healthcare Companies: Global Blood Therapeutics (NASDAQ: GBT) and Stemline Therapeutics (NASDAQ: STML)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Global Blood
Global Blood Therapeutics (GBT) Gets a Buy Rating from William Blair
William Blair analyst Raju Prasad maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) yesterday. The company’s
Wedbush Remains a Buy on Global Blood Therapeutics (GBT)
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Global Blood Therapeutics (GBT – Research
William Blair Maintains Their Buy Rating on Global Blood Therapeutics (GBT)
William Blair analyst Raju Prasad maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) today. The company’s